Analysts Eye Gains in Vanguard S&P Mid-Cap 400 Growth ETF
The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) shows strong potential for growth based on analyst targets.
By evaluating the ETF’s underlying holdings, we derived an implied analyst target price. For IVOG, this target stands at $127.55 per unit. This is significant, especially since IVOG is currently trading at about $115.85, indicating an expected upside of 10.10% according to analysts.
Several key holdings within IVOG demonstrate notable potential. FirstCash Holdings Inc (FCFS), trading at $111.41 per share, is projected to reach an average analyst target price of $135.00, suggesting an upside of 21.17%. Additionally, XPO Inc (XPO) shows 21.12% upside potential, with a recent price of $109.73, projected to hit an average target of $132.90. Lastly, IPG Photonics Corp (IPGP) is expected to rise from a recent price of $74.76 to an average target of $90.28, representing a 20.77% increase. Below is a visual comparison of the stock performance for FCFS, XPO, and IPGP over the last twelve months:
A summary of current analyst target prices for these stocks can be seen in the table below:
Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
---|---|---|---|---|
Vanguard S&P Mid-Cap 400 Growth ETF | IVOG | $115.85 | $127.55 | 10.10% |
FirstCash Holdings Inc | FCFS | $111.41 | $135.00 | 21.17% |
XPO Inc | XPO | $109.73 | $132.90 | 21.12% |
IPG Photonics Corp | IPGP | $74.76 | $90.28 | 20.77% |
As these stocks progress, one must consider whether analysts’ targets are realistic reflections of market conditions. Are they being optimistic, or are they grounded in recent industry changes? While a higher target can suggest confidence, it may also lead to future downgrades if the targets do not align with actual performance. Investors should conduct further research to assess these dynamics themselves.
10 ETFs with Most Upside to Analyst Targets »
Also see:
Gas Utilities Dividend Stocks
SFBS Insider Buying
NRIX Videos
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.